Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Frontline”

226 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 226 results

Not applicableStudy completedNCT07171827
What this trial is testing

Anti-CD30 (Brentuximab Vedotin) With AVD Versus ABVD Chemotherapy Protocol Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma

Who this might be right for
Anti-CD30BrentuximabDoxorubicin+4 more
Helwan University 60
Large-scale testing (Phase 3)Study completedNCT00046683
What this trial is testing

Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia

Who this might be right for
B Cell Chronic Lymphocytic Leukemia
Genzyme, a Sanofi Company 284
Testing effectiveness (Phase 2)Active Not RecruitingNCT05551936
What this trial is testing

Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Vaishalee Kenkre 42
Not applicableStudy completedNCT01678716
What this trial is testing

Impact of Behavior Change Communications and Market-based Approach to Delivering Micronutrient Powders on Stunting, Infant Feeding Practices and Anemia in Bangladesh

Who this might be right for
Child MalnutritionBreastfeedingComplementary Feeding+1 more
International Food Policy Research Institute 8,800
Testing effectiveness (Phase 2)Study completedNCT00618826
What this trial is testing

Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Barbara Ann Karmanos Cancer Institute 14
Testing effectiveness (Phase 2)UnknownNCT02834286
What this trial is testing

Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Hospital Universitario Dr. Jose E. Gonzalez 15
Large-scale testing (Phase 3)Study completedNCT00866203
What this trial is testing

HDS Plus PBPC Transplant Vs 4 More Courses of FrontLine Therapy in Pts With Aggressive NHL in PR After Induction Therapy

Who this might be right for
High-Grade Lymphomas
Gruppo Italiano Studio Linfomi 441
Testing effectiveness (Phase 2)Study completedNCT02649387
What this trial is testing

Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy

Who this might be right for
Stage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic LeukemiaStage III Chronic Lymphocytic Leukemia+1 more
Mayo Clinic 35
Early research (Phase 1)Active Not RecruitingNCT03932409
What this trial is testing

Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer

Who this might be right for
Endometrial Cancer
University of Oklahoma 45
Not applicableStudy completedNCT04555005
What this trial is testing

Mindfulness-based Crisis Intervention for COVID-19 Frontline Healthcare Workers During COVID-19

Who this might be right for
MindfulnessCOVID-19Healthcare Worker
Instituto de Investigación Hospital Universitario La Paz 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04974216
What this trial is testing

Study of Tafasitamab and Lenalinomide Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older

Who this might be right for
DLBCL
The Lymphoma Academic Research Organisation 71
Testing effectiveness (Phase 2)Ended earlyNCT02906696
What this trial is testing

Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI Failure

Who this might be right for
Blasts Under 15 Percent of Bone Marrow Nucleated CellsBlasts Under 15 Percent of Peripheral Blood White CellsBlasts Under 30 Percent of Bone Marrow Nucleated Cells+2 more
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT03407144
What this trial is testing

Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

Who this might be right for
Hodgkin Lymphoma
Merck Sharp & Dohme LLC 340
Large-scale testing (Phase 3)Active Not RecruitingNCT03901963
What this trial is testing

Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 200
Testing effectiveness (Phase 2)Looking for participantsNCT06765317
What this trial is testing

Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)High Grade B Cell Lymphoma
Memorial Sloan Kettering Cancer Center 42
Testing effectiveness (Phase 2)Ended earlyNCT03488225
What this trial is testing

Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionB Acute Lymphoblastic LeukemiaB Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Looking for participantsNCT05422066
What this trial is testing

Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma

Who this might be right for
DLBCL Germinal Center B-Cell Type
Li Zhiming 50
Testing effectiveness (Phase 2)UnknownNCT00628238
What this trial is testing

Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic LeukemiaCLLUntreated+3 more
Chronic Lymphocytic Leukemia Research Consortium 80
Testing effectiveness (Phase 2)Looking for participantsNCT04687176
What this trial is testing

Frontline Oral Arsenic Trioxide for APL

Who this might be right for
Acute Promyelocytic Leukemia
The University of Hong Kong 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT02726997
What this trial is testing

Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur)

Who this might be right for
Stage III Fallopian Tube Cancer AJCC v7Stage III Ovarian Cancer AJCC v6 and v7Stage III Primary Peritoneal Cancer AJCC v7+12 more
M.D. Anderson Cancer Center 18
Load More Results